immatics biotechnologies GmbH (IMTXW) Ownership

$0.01

$0.01 (-45.71%)
Last update: 12:01 PM EST
Day's range
$0.01
Day's range
$0.01

immatics biotechnologies GmbH Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LMR PARTNERS LLP 05/15/2025 1.34 M $21.19 K   3.88% 1.30%
ARISTEIA CAPITAL LLC 05/16/2025 838.88 K $14.93 K   0.88% 0.81%
D. E. SHAW & CO., INC. 05/15/2025 792.35 K $12.52 K   0.00% 0.77%
683 CAPITAL MANAGEMENT, LLC 05/15/2025 348.03 K $5.50 K   0.00% 0.34%
AEQUIM ALTERNATIVE INVESTMENTS LP 05/13/2025 252.74 K $3.99 K   0.00% 0.25%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2025 248.51 K $27.96 K   0.00% 0.24%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 187.20 K $2.96 K   0.00% 0.18%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2025 100.00 K $1.58 K   0.00% 0.10%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 77.09 K $347.69 K   0.00% 0.07%
WOLVERINE ASSET MANAGEMENT LLC 05/12/2025 64.38 K $1.02 K   -0.37% 0.06%
WEISS ASSET MANAGEMENT LP 05/15/2025 40.07 K $633   0.00% 0.04%
UBS GROUP AG 05/13/2025 2.70 K $43   1,799.30% 0.00%
WALLEYE CAPITAL LLC 05/14/2025 0 $0   -100.00% 0.00%
PRIVIUM FUND MANAGEMENT B.V. 05/09/2025 0 $0   -100.00% 0.00%

immatics biotechnologies GmbH institutional Ownership - FAQ's

During the previous two years, 16 institutional investors and hedge funds held shares of immatics biotechnologies GmbH. The most heavily invested institutionals were:

LMR Partners LLP: 1.34 M

ARISTEIA CAPITAL LLC: 838,876

D. E. Shaw & Co., Inc.: 792,353

683 Capital Management, LLC: 348,032

Aequim Alternative Investments LP: 252,741

Nantahala Capital Management, LLC: 248,506

4.17% of immatics biotechnologies GmbH stock is owned by institutional investors.

Institutional investors have bought a total of 4.48 M shares in the last 24 months. This purchase volume represents approximately $44.79 K in transactions.